Disulfide bonding and cysteine accessibility in the α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor subunit GluRD -: Implications for redox modulation of glutamate receptors

被引:24
|
作者
Abele, R
Lampinen, M
Keinänen, K
Madden, DR
机构
[1] Max Planck Inst Med Res, ICSRG, D-69120 Heidelberg, Germany
[2] Univ Helsinki, Dept Biosci, Div Biochem, FIN-00014 Helsinki, Finland
[3] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland
[4] VTT Biotechnol & Food Res, FIN-02044 Espoo, Finland
关键词
D O I
10.1074/jbc.273.39.25132
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Redox agents elicit a wide variety of effects on the ligand affinity and channel properties of ionotropic glutamate receptors and have been proposed as potential therapeutic agents for neuropathological processes. One such effect is the dithiothreitol (DTT)-induced increase in agonist affinity of certain ionotropic glutamate receptors (GluRs), presumably due to reduction of a disulfide bridge formed between cysteine residues conserved among all GluRs. Using biochemical techniques, this disulfide is shown to exist in the ligand-binding domain of the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor subunit GluRD, although GluRD homomeric receptors are not modulated by DTT. The disulfide is inaccessible to DTT, explaining the insensitivity of the intact receptor. Single mutants C260S and C315S show a 2-3-fold higher ligand affinity than wild-type, as observed for several intact GluRs, indicating that the affinity switch is completely contained within the ligand-binding domain. Also, mutants lacking the native disulfide show non-native oligomerization and dramatically reduced specific activity. These facts suggest that the disulfide bridge is required for the stability of the ligand-binding domain, explaining its conservation. A third cysteine residue in the ligand-binding domain exists as a free thiol, partially sequestered in a hydrophobic environment. These results provide a framework for interpreting a variety of GluR redox modulatory phenomena.
引用
收藏
页码:25132 / 25138
页数:7
相关论文
共 50 条
  • [31] THE ORGANIZATION OF THE GENE FOR THE FUNCTIONALLY DOMINANT ALPHA-AMINO-3-HYDROXY-5-METHYLISOXAZOLE-4-PROPIONIC ACID RECEPTOR SUBUNIT GLUR-B
    KOHLER, M
    KORNAU, HC
    SEEBURG, PH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (26) : 17367 - 17370
  • [32] Neuroprotective efficacy of YM872, an α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, after permanent middle cerebral artery occlusion in rats
    Takahashi, M
    Ni, JW
    Kawasaki-Yatsugi, S
    Toya, T
    Ichiki, C
    Yatsugi, SI
    Koshiya, K
    Shimizu-Sasamata, M
    Yamaguchi, T
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 287 (02): : 559 - 566
  • [33] Discovery of TAK-137 and TAK-653, clinical candidates of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiators with reduced agonistic activities
    Nakamura, Shinji
    Toyofuku, Masashi
    Honda, Eiji
    Imaeda, Toshihiro
    Yokota, Akihiro
    Sogabe, Satoshi
    Kunugi, Akiyoshi
    Kuno, Haruhiko
    Kosugi, Yohei
    Kori, Masakuni
    Miki, Takashi
    Kimura, Haruhide
    Kuroita, Takanobu
    Kaku, Tomohiro
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [34] LY503430, a novel α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease
    Murray, TK
    Whalley, K
    Robinson, CS
    Ward, MA
    Hicks, CA
    Lodge, D
    Vandergriff, JL
    Baumbarger, P
    Siuda, E
    Gates, M
    Ogden, AM
    Skolnick, P
    Zimmerman, DM
    Nisenbaum, ES
    Bleakman, D
    O'Neill, MJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 306 (02): : 752 - 762
  • [35] EFFECT OF NBQX, A NON-COMPETITIVE α-AMINO-3-HYDROXY-5-METHYLISOXAZOLE-4-PROPIONIC ACID RECEPTOR ANTAGONIST, ON THE SNEEZE-INDUCED, ACTIVE URETHRAL CONTINENCE REFLEX IN RATS
    Kawamorita, Naoki
    Kaiho, Yasuhiro
    Matsushita, Mabumi
    Yamashita, Shinichi
    Izumi, Hideaki
    Miyazato, Minoru
    Nakagawa, Haruo
    Arai, Yoichi
    JOURNAL OF UROLOGY, 2010, 183 (04): : E615 - E616
  • [36] Quinazolone-alkyl-carboxylic acid derivatives inhibit transmembrane Ca2+ ion flux to (+)-(S)-α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid
    Szárics, É
    Nyikos, L
    Barabás, P
    Kovács, I
    Skuban, N
    Temesváriné-Major, E
    Egyed, O
    Nagy, PI
    Kökösi, J
    Takács-Novák, K
    Kardos, J
    MOLECULAR PHARMACOLOGY, 2001, 59 (04) : 920 - 928
  • [37] THE GLUTAMATERGIC PATHWAY VIA α-AMINO-3-HYDROXY-5-METHYLISOXAZOLE-4-PROPIONIC ACID (AMPA) RECEPTORS PLAYS AN IMPORTANT ROLE IN THE CONTROL OF SNEEZE-INDUCED URETHRAL CONTINENCE REFLEXES IN RATS
    Kawamorita, Naoki
    Kaiho, Yasuhiro
    Izumi, Hideaki
    Nakagawa, Haruo
    Arai, Yoichi
    Yoshimura, Naoki
    JOURNAL OF UROLOGY, 2013, 189 (04): : E10 - E10
  • [38] PREPARATION OF DEUTERIUM LABELED ALPHA-AMINO-3-HYDROXY-5-METHYLISOXAZOLE-4-PROPIONIC ACID (AMPA)
    LAURIDSEN, J
    HONORE, T
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1981, 18 (10): : 1479 - 1484
  • [39] 5-HT1 and 5-HT2 receptor agonists blunt (±)-α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA)-stimulated GH secretion in prepubertal male rats
    Pinilla, L
    Gonzalez, LC
    Tena-Sempere, M
    Aguilar, E
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 144 (05) : 535 - 541
  • [40] YM872, a novel selective α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, reduces brain damage after permanent focal cerebral ischemia in cats
    Takahashi, M
    Ni, JW
    Kawasaki-Yatsugi, S
    Toya, T
    Yatsugi, SI
    Shimizu-Sasamata, M
    Koshiya, K
    Shishikura, JI
    Sakamoto, S
    Yamaguchi, T
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 284 (02): : 467 - 473